THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents ...

Dr Rav Sodi, Consultant Clinical Biochemist for Mid and South Essex NHS Foundation Trust, has partnered with Yorkshire- and Edinburgh-based med-tech company TestCard and global diagnostics ...

Jasper Therapeutics ( JSPR, Financial) has been on analysts' radar lately. JMP Securities analyst Silvan Tuerkcan gave the stock a "buy" rating and projected it to reach $70.00. The Tuerkcan's ...

Announced that the Phase 1 open label trial evaluating briquilimab ... About Jasper Jasper is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit ...

AMSBIO has launched the iMatrix Palette, a comprehensive kit designed to streamline cell culture and differentiation ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the fifteen ratings firms that are currently covering the stock, Ratings reports.

HeartFocus, the revolutionary, AI-enabled heart echo software by data-driven medtech company, DESKi, is proud to announce the launch of the HeartFocus ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

In a remarkable development for cancer research, patients with advanced-stage cancer have benefited from SUPLEXA, a ...